SALT LAKE CITY, Jan. 26 /PRNewswire/ -- GenData Research Corporation, a population genetics and biomarker discovery research company, announced today that it is changing the company name and identity to LineaGen Research Corporation. GenData was founded in 2002 by the State of Utah, the University of Utah, and the Huntsman Cancer Foundation and since established discovery collaborations with Amgen, Celera Diagnostics and Battelle. Former Utah Governor Michael Leavitt through the State's Industrial Assistance Fund spearheaded original funding for the company. The genetic research assets, including rights to use the Utah Population Database, were contributed by the University and the Huntsman Cancer Foundation.
"We believe our new company name, LineaGen, more accurately captures the value that our unique assets provide to the healthcare industry, especially biotechnology and pharmaceutical companies," said Stephen Prescott, Chief Executive Officer of LineaGen. "Our new name represents the unique attributes of Utah's population and our research programs that combine genetic discovery in large "high-risk" families with genomic research in large association studies of unrelated individuals."
To coincide with the new name, LineaGen Research Corporation has launched a new website located at http://www.lineagen.org/. The website provides information about the company, resources and assets, research, products and services.
LineaGen Research Corporation is biotechnology research and licensing company that utilizes a powerful population genetics discovery platform to identify and validate biomarkers, coordinate clinical trials, and identify health-promoting and disease-causing genetic factors. LineaGen provides industry partners with breakthrough genetic research programs that leverage an extensive biosample repository coupled with detailed clinical data and decades of medical and genetic information from both population-based studies and studies on multigenerational families. LineaGen's key asset is its ability to provide commercial access to research using the Utah Population Database and Utah Genetic Reference Project.
Headquartered in Salt Lake City, Utah, LineaGen draws on a proven process for genetic discovery at the University of Utah that has led to the discovery of multiple disease-causing genes in cancer, heart disease, and neurological disorders. This history of success has been expanded to disease areas including autoimmune and inflammatory disorders, respiratory disease, metabolic disorders, central nervous system disorders, and age-related conditions.
About Utah Population Database
The Utah Population Database is an unmatched integration of vital statistics, clinical records, and genealogical information. Currently, the Utah Population Database comprises more than 7 million linked records, including genealogical records, population records, and vital statistics that are linked to medical information.
About Utah Genetic Reference Project
The Utah Genetic Reference Project is an extensive collection of genotypic and phenotypic characteristics collected from more than 600 individuals representing approximately 45 Utah families. These large multigenerational families donated their DNA to the Centre d'Etude du Polymorphisme Humain (CEPH) approximately twenty years ago, and since then their DNA has been a critical resource in the mapping studies that identified genes for a number of genetic diseases and disorders.
Michael Paul, COO
MacDougall BioCommunications, Inc.
LineaGen Research Corporation